Literature DB >> 11180484

Prevalence and pharmacological management of behavioural and psychological symptoms amongst dementia sufferers living in care environments.

M Margallo-Lana1, A Swann, J O'Brien, A Fairbairn, K Reichelt, D Potkins, P Mynt, C Ballard.   

Abstract

BACKGROUND: Behavioural and psychological symptoms in dementia (BPSD) are a common reason for placement in long term care and are often associated with indiscriminate prescription of psychotropic medication. AIMS: To determine the prevalence of BPSD in care environments, their relationship with severity of dementia and the pattern of psychotropic medication.
METHODS: Two hundred and thirty-one elderly residents (39% living in social care facilities and 61% in nursing home care) were assessed using a range of standardised psychiatric schedules. Additional information about the residents and medication was obtained from professional carers.
RESULTS: Overall 90% of residents had dementia, 79% of whom had clinically significant BPSD with 58% receiving psychotropic medication. There was no difference in the prevalence of BPSD between social and nursing care. Depression was most common in people with mild dementia, whilst delusions arose most frequently in those with moderate dementia and aberrant motor behaviour had a high prevalence in people with severe dementia.
CONCLUSION: BPSD are common in elderly people with dementia living in care environments. More rigorous guidelines are needed pertaining to the prescription and monitoring of medication and the need to disseminate skills regarding psychosocial management approaches to care staff. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11180484     DOI: 10.1002/1099-1166(200101)16:1<39::aid-gps269>3.0.co;2-f

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  58 in total

Review 1.  Second-generation antipsychotics in dementia: beyond safety concerns. A clinical, systematic review of efficacy data from randomised controlled trials.

Authors:  Salvatore Gentile
Journal:  Psychopharmacology (Berl)       Date:  2010-07-27       Impact factor: 4.530

2.  Caring for people with dementia.

Authors:  Murna Downs; Barbara Bowers
Journal:  BMJ       Date:  2008-01-10

3.  Prevalence of Depression, Anxiety and PTSD in People with Dementia: a Systematic Review and Meta-Analysis.

Authors:  J K Kuring; J L Mathias; L Ward
Journal:  Neuropsychol Rev       Date:  2018-12-07       Impact factor: 7.444

Review 4.  Impact of rivastigmine on caregiver burden associated with Alzheimer's disease in both informal care and nursing home settings.

Authors:  George T Grossberg
Journal:  Drugs Aging       Date:  2008       Impact factor: 3.923

5.  Use of antipsychotics among elderly nursing home residents with dementia in the US: an analysis of National Survey Data.

Authors:  Pravin Kamble; Hua Chen; Jeffrey T Sherer; Rajender R Aparasu
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

Review 6.  Withholding, discontinuing and withdrawing medications in dementia patients at the end of life: a neglected problem in the disadvantaged dying?

Authors:  Carole Parsons; Carmel M Hughes; A Peter Passmore; Kate L Lapane
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

7.  Behavioural and psychological symptoms in general hospital patients with dementia, distress for nursing staff and complications in care: results of the General Hospital Study.

Authors:  J B Hessler; M Schäufele; I Hendlmeier; M N Junge; S Leonhardt; J Weber; H Bickel
Journal:  Epidemiol Psychiatr Sci       Date:  2017-01-09       Impact factor: 6.892

8.  Neuropsychiatric symptoms in community-dwelling Mexican-Americans: results from the Hispanic Established Population for Epidemiological Study of the Elderly (HEPESE) study.

Authors:  Ricardo Salazar; Donald R Royall; Raymond F Palmer
Journal:  Int J Geriatr Psychiatry       Date:  2014-05-16       Impact factor: 3.485

9.  Individualized Music Program is Associated with Improved Outcomes for U.S. Nursing Home Residents with Dementia.

Authors:  Kali S Thomas; Rosa Baier; Cyrus Kosar; Jessica Ogarek; Alissa Trepman; Vincent Mor
Journal:  Am J Geriatr Psychiatry       Date:  2017-04-14       Impact factor: 4.105

10.  Zotepine for behavioural and psychological symptoms in dementia: an open-label study.

Authors:  Michael K Rainer; Hermann A M Mucke; Christine Krüger-Rainer; Manfred Haushofer; Sigfried Kasper
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.